Validation of the picoAMH assay on the Dynex DS2 platform

OBJECTIVES: Anti-Müllerian hormone (AMH) is increasingly used as a biomarker of ovarian reserve in clinical practice, and is used both for management of fertility treatments and prediction of menopause. We sought to validate the newly FDA-approved Ansh Laboratories MenoCheck picoAMH ELISA on the Dyn...

Descripción completa

Detalles Bibliográficos
Autores principales: Garnett, Emily R, Jariwala, Purviben, Rector, Kesha, Gibbons, William E, Zarutskie, Paul W, Devaraj, Sridevi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804432/
https://www.ncbi.nlm.nih.gov/pubmed/31646166
http://dx.doi.org/10.1016/j.plabm.2019.e00140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804432/
https://www.ncbi.nlm.nih.gov/pubmed/31646166
http://dx.doi.org/10.1016/j.plabm.2019.e00140

Ejemplares similares